Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis (Q28258638)

1

0 references

author name string

Marcel Zwahlen

2

0 references

Christoph Minder

3

0 references

Sarah T O'Dwyer

4

0 references

Stephen M Shalet

The effects of insulin-like growth factors on tumorigenesis and neoplastic growth

5

0 references

language of work or name

English

0 references

publication date

24 April 2004

0 references

published in

The Lancet

0 references

volume

363

0 references

page(s)

1346-53

0 references

issue

9418

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Insulin-like growth factor physiology and cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Role of the insulin-like growth factor family in cancer development and progression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Insulin, insulin-like growth factors and colon cancer: a review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Cellular actions of the insulin-like growth factor binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Methods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

High-risk colorectal adenomas and serum insulin-like growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Explaining heterogeneity in meta-analysis: a comparison of methods.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Serum insulin-like growth factor-I and breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Insulin-like growth factor I, IGF-binding protein 3, and lung cancer risk in a prospective study of men in China

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Determination of IGF-I, IGF-II, IGFBP-2, and IGFBP-3 levels in serum and plasma: comparisons using the Bland-Altman method.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Physical capacity influences the response of insulin-like growth factor and its binding proteins to training.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of beta-catenin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Estradiol enhances the stimulatory effect of insulin-like growth factor-I (IGF-I) on mammary development and growth hormone-induced IGF-I messenger ribonucleic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Free insulin-like growth factors (IGF-I and IGF-II) in human serum.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Immunoassay of insulin-like growth factor-binding protein-3 (IGFBP-3): new means to quantifying IGFBP-3 proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

Intervention Studies in Exercise and Cancer Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916044-3

7 January 2021

10.1016/S0140-6736(04)16044-3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

release_hlnioi7e2neutlegwrrthiwuam

118996

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hlnioi7e2neutlegwrrthiwuam

24 November 2022

mapped directly with Wikidata item

118996

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference